Wang Bo 王博

… Alternative Names

王博オウハク

Less

Researcher Number	80842765
Affiliation (Current)	2023: 京都大学, iPS細胞研究所, 特定研究員
Affiliation (based on the past Project Information) *help	2022: 京都大学, iPS細胞研究所, 特定研究員 2019 – 2020: 京都大学, iPS細胞研究所, 研究員
Review Section/Research Field	Principal Investigator 0803:Pathology, infection/immunology, and related fields / Basic Section 49070:Immunology-related
Keywords	Principal Investigator immune rejection / iPSC derived T cells / gene editing / iPSC-derived T cells / iPSCs / Activated iPS-T cells / PVR / adoptive T cells therapy / iPSC / CRISPR Screening

Polled In Vivo CRISPR-Cas9 Screening in iPSCs to generate immune-evasive iPSCsPrincipal Investigator
- Principal Investigator
  
  王博
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 49070:Immunology-related
- Research Institution
  Kyoto University
Generation of universal donor cell souse for adoptive T cell therapy using iPSC technologyPrincipal Investigator
- Principal Investigator
  
  Wang Bo
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Review Section
  
  0803:Pathology, infection/immunology, and related fields
- Research Institution
  Kyoto University

All 2021 2020 2019

All Journal Article Presentation

[Journal Article] Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells2021
- Author(s)
  Bo Wang, Shoichi Iriguchi, Masazumi Waseda, Norihiro Ueda, Tatsuki Ueda, Huaigeng Xu, Atsutaka Minagawa, Akihiro Ishikawa, Hisashi Yano, Tomoko Ishi, Ryoji Ito, Motohito Goto, Riichi Takahashi, Yasushi Uemura, Akitsu Hotta and Shin Kaneko
- Journal Title
  
  Nature Biomedical Engineering
  
  Volume: in press Pages: 429-440
- DOI
  10.1038/s41551-021-00730-z
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K23863, KAKENHI-PROJECT-19K16688, KAKENHI-PROJECT-20K06477
[Presentation] Universal T cell generation for off-the-shelf cancer immunotherapy from gene edited allogeneic iPSCs2020
- Author(s)
  Bo Wang (王　博)
- Organizer
  第19回日本再生医療学会総会
- Data Source
  KAKENHI-PROJECT-19K23863
[Presentation] Universal T cell generation for off-the-shelf cancer immunotherapy from gene edited allogeneic iPSCs2020
- Author(s)
  Bo Wang, Shoichi Iriguchi, Masazumi Waseda, Norihiro Ueda, Tatsuki Ueda, Huaigeng Xu, Atsutaka Minagawa, Akihiro Ishikawa, Yasushi Uemura, Akitsu Hotta and Shin Kaneko
- Organizer
  第19回日本再生医療学会総会
- Data Source
  KAKENHI-PROJECT-19K23863
[Presentation] Enhanced stealth property on iPSC to generate universal T cell source for allogeneic cancer immunotherapy2019
- Author(s)
  Bo Wang (王　博)
- Organizer
  17th International Congress of Immunology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K23863
[Presentation] Generation of "universal iPSC" with enhanced stealth ty on iPSC for allogeneic T cell immunotherapy2019
- Author(s)
  Bo Wang (王　博)
- Organizer
  第11回日本血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-19K23863

1. ITO Ryoji

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 南川淳隆

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Wang Bo 王博

王博オウハク

Research Projects

Research Products

Co-Researchers

Polled In Vivo CRISPR-Cas9 Screening in iPSCs to generate immune-evasive iPSCsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Generation of universal donor cell souse for adoptive T cell therapy using iPSC technologyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] Universal T cell generation for off-the-shelf cancer immunotherapy from gene edited allogeneic iPSCs2020

Author(s)

Organizer

Data Source

[Presentation] Universal T cell generation for off-the-shelf cancer immunotherapy from gene edited allogeneic iPSCs2020

Author(s)

Organizer

Data Source

[Presentation] Enhanced stealth property on iPSC to generate universal T cell source for allogeneic cancer immunotherapy2019

Author(s)

Organizer

Data Source

[Presentation] Generation of "universal iPSC" with enhanced stealth ty on iPSC for allogeneic T cell immunotherapy2019

Author(s)

Organizer

Data Source

Wang Bo 王 博

王 博 オウ ハク

Research Projects

Research Products

Co-Researchers

Polled In Vivo CRISPR-Cas9 Screening in iPSCs to generate immune-evasive iPSCsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Generation of universal donor cell souse for adoptive T cell therapy using iPSC technologyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] Universal T cell generation for off-the-shelf cancer immunotherapy from gene edited allogeneic iPSCs2020

Author(s)

Organizer

Data Source

[Presentation] Universal T cell generation for off-the-shelf cancer immunotherapy from gene edited allogeneic iPSCs2020

Author(s)

Organizer

Data Source

[Presentation] Enhanced stealth property on iPSC to generate universal T cell source for allogeneic cancer immunotherapy2019

Author(s)

Organizer

Data Source

[Presentation] Generation of "universal iPSC" with enhanced stealth ty on iPSC for allogeneic T cell immunotherapy2019

Author(s)

Organizer

Data Source

Wang Bo 王博

王博オウハク